ProBDNF/p75NTR/sortilin pathway is activated in peripheral blood of patients with alcohol dependence by Zhou, L. et al.
Zhou et al. Translational Psychiatry  (2017) 7:2 
DOI 10.1038/s41398-017-0015-4 Translational Psychiatry
ART ICLE Open Ac ce s s
ProBDNF/p75NTR/sortilin pathway is
activated in peripheral blood of patients
with alcohol dependence
Li Zhou1,2, Jing Xiong2,3, Chun-Sheng Ruan2,4, Ye Ruan1, Dennis Liu5,6, Jian-Jun Bao1 and Xin-Fu Zhou2,4
Abstract
Alcohol dependence is a worldwide problem with a great social and economic burden in many countries. A number
of studies have suggested that BDNF (mature BDNF) and its precursor (proBDNF) play important roles in the alcohol
dependence. However, what roles of the mBDNF/proBDNF pathways play during the pathological process of alcohol
dependence are not clearly understood. In our clinical study, peripheral blood was sampled from 30 male patients
with alcohol dependence and 50 healthy males (as control). The protein levels of proBDNF, p75NTR, sortilin, mBDNF,
TrkB and mRNA levels of BDNF, p75NTR, sortilin, and TrkB were detected in the peripheral blood in our study. We found
that the protein levels of proBDNF and p75NTR were increased, but not the sortilin protein level; while the TrkB protein
level was decreased in the alcohol dependence patients compared with healthy controls. Moreover, the mRNA levels
of p75NTR and sortilin from the lymphocytes were slightly increased; while BDNF and TrkB were significantly decreased.
The ELISA results of mBDNF and TrkB were declined in the alcohol dependence group. The levels of mBDNF and TrkB
were negatively correlated with the average amount of daily ethanol consumption, and the levels of proBDNF, p75NTR
and sortilin were positively correlated with the average amount of ethanol consumption per day. The ratio of proBDNF
to mBDNF was altered in alcohol dependence patients. The balance between the proBDNF/p75NTR and mBDNF/TrkB
signalling pathways appeared dysregulated in alcohol dependence. Our results suggested that both pathways may
participate in the complex processes of alcohol dependence.
Introduction
Brain-derived neurotrophic factor (BDNF) is under a
pivotal role in the psychiatric disorders, including alcohol
dependence1–3. Alcohol dependence or alcohol abuse is a
worldwide problem with a great social and economic
burden in many countries. Gabbard has stated in his book
that “The most common substance of abuse/dependence
in patients presenting for treatment is alcohol.”4 The
aetiology of alcohol dependence is not clear, but it is
known that both genetic causes of predisposition and
environmental factors play critical roles in it5.
Nonetheless, how the genetic and environmental factors
interact to promote the pathogenesis of alcohol depen-
dence requires further investigations.
Human alcoholics, in both men and women show a
significant volume loss (shrinkage) in cortical and sub-
cortical brain structures, which include both grey and
white matters. Ethanol can also cause neuronal cell death,
impair differentiation, reduce neuronal numbers and
weaken neuronal plasticity. BDNF can significantly
reverse the ethanol-induced neuronal toxicity6–8. BDNF is
synthesised as a precursor molecule (proBDNF), which is
enzymatically processed to mature BDNF (mBDNF) and
BDNF predomain. ProBDNF and mBDNF play different,
even opposite roles in neuronal survival, differentiation
and plasticity9. Many studies show that mBDNF and its
high-affinity receptor, tyrosine kinase receptor (TrkB),
play pivotal roles in mediating neuronal survival and
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growth. Its precursor (proBDNF) can induce neuronal
apoptosis via binding with p75 neurotrophin receptor
(p75NTR) and sortilin10–12. Little is known about their
levels in the diseased conditions. Chronic ethanol expo-
sure can also remodel the BDNF gene at the chromatin
level, contribute to the development and maintenance of
addiction13–15. The BDNF and TrkB levels decreased in
alcohol-dependent patients, increased after abstinence.
Furthermore, the p75NTR level was the opposite of those
of BDNF and TrkB during alcohol dependence and
abstinence16. Moreover, excessive alcohol intake would
lead to neuroadaptation by destructing BDNF/TrkB sig-
nalling pathway. When given p75NTR modulator, the
excessive alcohol intake would significantly reduce in
rats17. Since proBDNF and mBDNF have opposite func-
tions, expression levels of proBDNF and mBDNF in
alcohol dependence also should be distinguished. We
postulate that chronic ethanol exposure can alter the
metabolism of BDNF, leading to the imbalance of
proBDNF vs. mBDNF and the changes of signalling
pathways of proBDNF/p75NTR/sortilin and mBDNF/
TrkB. In the present study, we have tested this hypothesis
in male patients with alcohol dependence.
Materials and methods
Subjects
The study was based on clinical samples, which was
approved by the Ethics Committee of the Mental Hospital
of Yunnan Province, and all the experimental procedures
were conducted in accordance with the Helsinki
Declaration of 1975, as revised in 1983. Thirty alcohol
dependence male patients who went to detoxification
treatment voluntarily were recruited from detoxification
treatment unit in the Mental Hospital of Yunnan Pro-
vince, China, from September 2010 to May 2011. Patients
were enrolled to participate in the study after they had
signed the informed consents for participation. The Chi-
nese version of the Mini International Neuropsychiatric
Interview (MINI) and the alcohol use disorders
identification test (AUDIT) were used to screen their
psychiatric and drinking conditions to confirm that they
met the diagnosis of alcohol dependence according to the
International Statistical Classification of Diseases and
Related Health Problems 10th Revision (ICD-10) criteria.
Excluded criteria were those: who were comorbidity with
other current non-nicotine substance abuse or depen-
dence, including sedatives; who used sedatives in the past
one month; who had significant physical illnesses; who
had other psychiatric disorders, such as schizophrenia,
bipolar disorder, or major depressive disorder and suf-
fered from severe cognitive impairment with difficulty in
understanding the study content. The drinking histories
such as: age at first intoxication and the average daily
amount of alcohol consumption (which was amended into
pure ethanol) in last one month were collected. All the
alcohol dependence patients received oral Oxazepam
30–60 mg according to the severity of withdrawal symp-
toms to alleviate the withdrawal symptoms.
The control group (shown in Table 1) included 50
healthy male subjects without severe physical illnesses and
psychiatric disorders who came to the clinic for a routine
physical examination. The exclusion criteria of healthy
controls were: (1) meet the diagnostic criteria of alcohol
abuse/dependence in the past; (2) the average daily con-
sumption of alcohol was more than 50 g (pure ethanol)
during the last three months; (3) lifetime diagnosis of
dementia, schizophrenia, schizoaffective disorder or mood
disorder according to the ICD-10 by using the Chinese
version of MINI and AUDIT.
All the participants (Han nationality) were from the
Kunming City of Yunnan Province. They were similar in
age, gender and ethnicity with the alcohol dependence
patients.
The mRNA levels of BDNF, p75NTR, sortilin and TrkB
in lymphocytes were measured with quantitative real-time
PCR; the protein levels of proBDNF, p75NTR, sortilin and
TrkB in lymphocytes were measured with western blot-
ting; and the levels of mBDNF and TrkB in the serum
Table 1 The demographic data of the alcohol dependence group and control group








Ethnicity Han nationality Han nationality n.a.
Average lifetime drinking (years) n.a. 16.971 ± 5.8. n.a.
Average daily amount of ethanol consumption (gram) 0 + 50 500 + 250 < 0.001
AUDIT scores 1 + 1 23.5 + 7.25 < 0.001
There were no significant differences of the average ages between control group and alcohol dependence group. The differences of average daily amount of ethanol
consumption and AUDIT scores were significant between the two groups (***P < 0.001)
n.a. not applicable
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were measured with enzyme-linked immunosorbent assay
(ELISA). Because some blood samples had not enough
lymphocytes to complete both the western blotting and
quantitative real-time PCR experiments, so there were
28 samples of alcohol dependence and 46 control samples
in the quantitative real-time PCR experiment; there were
27 samples of alcohol dependence and 45 control samples
in the lymphocytes western blotting experiment.
Blood sampling
After having obtained the permission, the coagulant
and anti-coagulant vacuum blood collection tubes with
Complete Proteinase Inhibitor Cocktail (cat.
#04693116001, Roche Diagnostics, Indianapolis, IN,
USA), plasminogen activator inhibitor 1 (PAI-1) (cat.
#A8111, Sigma-Aldrich) and the furin inhibitor I (Lot.
#D00078005, Calbiochem) were used to get 2–5ml per-
ipheral blood on the next morning of admission.
Isolation of serum
Human blood obtained from the antecubital vein was
collected in coagulant tubes and kept on ice for 4 h, and
then centrifuged at 1500×g, 4 °C for 10min. The serum
(top layer with light yellow colour) was carefully collected
and stored at −80 °C before further experiment.
Isolation of lymphocytes
Blood was obtained from the antecubital vein after
overnight fasting in anti-coagulant tubes and kept at 4 °C.
The human lymphocytes separation medium (cat.#
P8610-200, Solarbio, China) was used to separate the
lymphocytes from the blood and kept in −80 °C before
total RNA and protein extraction.
Protein isolation from lymphocytes
The detailed procedures were described in our previous
paper18. Briefly, the samples were homogenised in RIPA
buffer (containing 50mM Tris, 150mM NaCl, 1.0% Triton
x-100, 0.5% sodium deoxycholate, 0.1% SDS) supplemented
with Complete Proteinase Inhibitor Cocktail (cat.
#04693116001, Roche, USA), Plasminogen Activator Inhi-
bitor 1(PAI-1) (cat.#A8111, Sigma-Aldrich, USA) and furin
inhibitor I (Lot.#D00078005, Calbiochem, USA). After
centrifugation at 1500×g for 30min, the supernatant was
collected and the total protein was quantified using BCA
Protein Assay kit (cat.#CW0014, Cwbiotech, China).
Western blotting
We had interpreted the details in our previously
paper18. Briefly, 50 μg lymphocyte protein was separated
by running a SDS-PAGE gel, and transferred onto a
polyvinylidene fluoride (PVDF) membrane (400 mA, 2 h).
The membrane was blocked with 5% skimmed milk dis-
solved in 0.1% Tween-20/Tris-buffered saline (TBST) at
room temperature for 1 h. Followed by incubation of
primary antibodies (sheep anti-human proBDNF 1:200,
from professor Xin-Fu Zhou’s laboratory; goat anti-
human p75NTR 1:250, cat.#sc-6188, Santa Cruz, USA;
rabbit anti-human sortilin 1:1000, cat.#ab16640, Abcam,
USA; rabbit anti-human TrkB 1:1000, cat.#07-225, Milli-
pore, USA; mouse anti-human beta-tubulin 1:1000, cat.
#T5168, Sigma, USA) at 4 °C, overnight. After washed in
TBST, the membranes were further incubated with
horseradish peroxidase-conjugated anti-rabbit/mouse/
sheep/goat specie-specific secondary antibodies (cat.#sc-
2020, Santa Cruz, USA; cat.#CW0103, Cwbiotech, China)
at room temperature for 1 h. After washed again in TBST,
enhanced chemiluminescent (ECL) substrate (cat.
#cw0049, Cwbiotech, China) was applied on the mem-
brane before imaging using ChemiDocTM XRS+ System
(Bio-Rad, USA). For quantify the protein level in lym-
phocytes, beta-tubulin was blotted as loading control. The
blots were analysed using ImageJ software (NIH, USA).
Quantitative real-time PCR
The methodology of quantitative real-time PCR was
described in our previous paper18. Briefly, the total RNA
was extracted from the lymphocytes using the Trizol
reagent (cat.#15596-026, Invitrogen, USA). Com-
plementary DNA was synthesised using PrimeScript® RT
reagent Kit Perfect Real Time (Code: DRR037A, TaKaRa,
China) according to the manufacturer’s instruction. Gene
expression levels of BDNF, TrkB, p75NTR and sortilin
were detected by running quantitative real-time PCR in
ABI 7300 (ABI Applied Biosystems, USA) using SYBR
Green mix. The gene expression of β-actin was detected












The primers for BDNF, TrkB and p75NTR were derived
from Fauchais19 and the primers for sortilin were self-
designed. The PCR cycling conditions were: 95 °C for 10
min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 1
min. Samples were processed in technical duplicates and a
melting analysis was performed in each sample at the end
of PCR. The Ct value was determined for target genes
(BDNF, TrkB, p75NTR and sortilin) and the endogenous
control β-actin gene in each sample. The differences
between target genes and the control Ct were determined
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for each sample, resulting in the ΔCt value. To determine
relative differences in mRNA expression between differ-
ent target genes, the 2−ΔΔCt was applied.
ELISA assay of mBDNF and TrkB
As previously described in Zhou et al.18 in the year of
2013 and proved by Lim et al.20 in the year of 2015, the
ELISA steps were as following: capture antibody (protein
G-purified mouse anti-mBDNF monoclonal antibody,
B34D10, made in house) was diluted to 2 ug/ml in coating
buffer (50 mM Carbonate) and coated to a 96-well
microplate (100 ul/well). The plate was then incubated
at 37 °C for 1 h. After being washed with phosphate-
buffered saline (PBS) for three times, the plate was added
with blocking buffer (PBS-BSA, 150 ul/well) and incu-
bated at 37 °C for 1 h again. Afterwards, the sera and
mBDNF standards (0.125–2 ug/ml) were diluted properly
and added into the plate (100 ul/well). The plate was
incubated at 37 °C for 1 h, and then was washed with wash
buffer (four times). The detecting antibody was diluted (to
2.5 ug/ml) and added to the plate (100 ul/well). Then, the
plate was incubated at 37 °C for 1 h. After being washed
with wash buffer for four times, the plate was added with
TMB substrate (100 ul/well). After 10–15min, 1 N sul-
phuric acid was added to stop the reaction. Then, the
plate was read at 450 nm in a microplate reader (Model
Sunrise, TECAN, Germany). The concentration of BDNF
was calculated by comparing with the standards. Serum
levels of TrkB were determined by the commercial human
TrkB ELISA kit (Sino Biological, Inc., Beijing, China)
according to the manufacturer’s instructions.
Statistical analyses
All statistical analyses were performed using Statistical
Product and Service Solutions (SPSS) 19.0 Version. The
data of average ages and average lifetime drinking was
presented as mean± SD, Student’s t-test was used for the
comparison. The average ethanol consumption, AUDIT
scores and mBDNF ELISA results was presented as
median+ Interquartile range (IQR), because they were
not normality ones, and the Mann–Whitney U-test was
used to analyse them. The rest results were given as mean
± standard error of mean (SEM), and Student’s t-test was
used for the comparison. The Spearman’s correlation test
was used for analysing the correlations of the average
daily ethanol consumption with proBDNF, mBDNF,
p75NTR, sortilin and TrkB. P< 0.05 (two-tailed) was
considered as statistically significant.
Results
The demographic data of the patient group and control
group was shown in Table 1. There were no significant
differences of the average ages between control group and
alcohol dependence group (t= 1.373, P= 0.172, Student’s
t-test). The average daily amount of ethanol consumption
and AUDIT scores were significantly higher in alcohol
dependence group than control group (average daily
amount of ethanol consumption: z=−8.9315.098, P<
0.001; AUDIT scores: z=−7.531, P< 0.001, Mann–
Whitney U-test).
ProBDNF/p75NTR/sortilin signalling was activated in
patients with alcohol dependence
ProBDNF preferentially binds to its co-receptors
(p75NTR and sortilin) to perform the cascade roles in
neuronal apoptosis. The lymphocyte mRNA levels of
p75NTR (t=−1.305, P= 0.227, Student’s t-test; Fig. 1a)
and sortilin (t=−1.394, P= 0.176, Student’s t-test;
Fig. 1b) were not statistically different from those in the
alcohol dependence group (n= 28) compared to the
control group (n= 46). Moreover, the lymphocyte protein
levels of proBDNF (t= 3.758, P= 0.001, Student’s t-test;
Fig. 2a) and p75NTR (t=−2.610, P= 0.014, Student’s
t-test; Fig. 2b) were significantly higher in the alcohol
dependence group (n= 27) than in the control group
(n= 45); while the protein level of sortilin (t= 0.706,
P= 0.494, Student’s t-test; Fig. 2c) was not statistically
significant between the two groups. The above results
suggest that proBDNF, p75NTR and sortilin were acti-
vated in patients with alcohol dependence.
mBDNF/TrkB signalling was deactivated in patients with
alcohol dependence
By binding to TrkB receptor, mBDNF acts a beneficial
role in neuronal survival, which is opposing to proBDNF/
p75NTR/sortilin pathway. The lymphocyte mRNA levels
of BDNF (t=−2.804, P= 0.01, Student’s t-test; Fig. 1c)
and TrkB (t= 5.733, P< 0.001, Student’s t-test; Fig. 1d)
were significantly reduced in the alcohol dependence
group (n= 28) compared to the control group (n= 46).
The ELISA result of mBDNF was: n= 30, median+ IQR
= 17.554+ 17.29 ng/ml in alcohol dependence group and
the result of health controls was: n= 50, median+ IQR=
27.334+ 12.55 ng/ml. The serum level of mBDNF was
significantly decreased (z=−2.982, P= 0.003, Mann–
Whitney U-test; Fig. 3a) in alcohol dependence group
(n= 30) when compared with healthy controls (n= 50).
The TrkB protein level from lymphocytes was decreased
(t=−2.598, P= 0.013, Student’s t-test; Fig. 2d) in the
alcohol dependence group (n= 27) compared to the
control group (n= 45). Through the ELISA methods, we
also found a reduced TrkB level in alcohol dependence
group. The ELISA result of TrkB was: n= 30, mean±
SEM= 423.373± 29.512 pg/ml in alcohol dependence
group and the result of health controls was: n= 50, mean
± SEM= 551.873± 34.263 pg/ml. The serum level of
TrkB was significantly decreased (t=−2.984, P= 0.004,
Student’s t-test; Fig. 3b) in alcohol dependence group (n
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= 30) when compared with healthy controls (n= 50).
These results suggested that mBDNF and TrkB are
deactivated in patients with alcohol dependence.
The protein levels of proBDNF/p75NTR/sortilin in
lymphocytes were positively correlated with average daily
consumption of alcohol
We analysed the relationship between the protein levels
of proBDNF/p75NTR/sortilin in lymphocytes and average
daily consumption of alcohol. The data showed that the
lymphocyte levels of proBDNF, p75NTR and sortilin were
positively correlated with the daily ethanol consumption in
the alcohol dependence group (n= 27; proBDNF: r= 0.417,
P= 0.031, Fig. 4a; p75NTR: r= 0.476, P= 0.012; Fig. 4b;
sortilin: r= 0.708, P= 0.001, Fig. 4c; Spearman’s correlation
test). These results suggested that chronic excessive alcohol
intake might enhance the role of proBDNF/p75NTR/sor-
tilin signalling pathway in alcohol dependence.
The protein levels of mBDNF/TrkB in lymphocytes and
serum were negatively correlated with average daily
consumption of alcohol
We further analysed the relationship between the pro-
tein levels of mBDNF/TrkB in lymphocytes/serum and
average daily consumption of alcohol. The Spearman’s
correlation test results showed that the serum level of
mBDNF (n= 30, r=−0.438, P= 0.015, Fig. 4e) and the
lymphocyte/serum level of TrkB (lymphocyte: n= 27,
r=−0.394, P= 0.042, Fig. 4d; serum: n= 30, r=−0.398,
P= 0.029, Fig. 4f) were negatively correlated with the
daily ethanol consumption in the alcohol dependence
group. These data suggested that chronic excessive alco-
hol intake would suppress the mBDNF/TrkB signalling
pathway in alcohol dependence.
The ratio of proBDNF and mBDNF was out of balance in
the alcohol dependence patients
Given that the proBDNF/p75NTR/sortilin pathway and
the mBDNF/TrkB pathway acts in an opposing way in the
pathogenesis of alcohol dependence, we then analysed the
relative ratio of lymphocyte proBDNF (detected by wes-
tern blot) to the serum mBDNF protein level (detected by
ELISA assay) in both alcohol dependence group and
control groups. Our results showed that the correlation
between proBDNF level and mBDNF level in the control
group (n= 45, r=−0.4238, P= 0.0037; Spearman’s cor-
relation test) and in the alcohol dependence group (n=
45, r=−0.5340, P= 0.0041; Spearman’s correlation test)
were significant. Furthermore, the relative ratio of
proBDNF to mBDNF in the alcohol dependence group



















































Fig. 1 The mRNA levels of BDNF, TrkB, p75NTR and sortilin in lymphocytes of patients with alcohol dependence and controls. The mRNA
levels of p75NTR (a) and sortilin (b) were slightly increased; but the mRNA levels of BDNF (c) and TrkB (d) were significantly decreased in the
lymphocytes of patients with alcohol dependence (n = 28) compared to the controls (n = 46). Quantitative real-time PCR was performed to measure
the mRNA level of each sample, and β-actin was measured as control (each measurement was performed in triplicates). All the data were presented
in mean ± SEM and analysed by Student’s t-test (**P < 0.01, ***P < 0.001)






















































































Fig. 2 The protein levels of proBDNF, p75NTR, sortilin and TrkB in lymphocytes of patients with alcohol dependence and healthy controls.
The lymphocytes protein levels of proBDNF (a) and p75NTR (b) were increased, but not the protein levels of sortilin (c). The lymphocytes protein level
of TrkB (d) was decreased in the alcohol dependence group (n = 27) compared to the controls (n = 45). Western blots were performed to measure
the protein level of each sample, β-tubulin was measured as control. All the data were presented in mean ± SEM and analysed by Student’s t-test
(*P < 0.05, **P < 0.01)
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(n= 27) to the control group was significantly higher than
that in the control group (n= 45; t= 4.135, P< 0.001,
Student’s t-test; Fig. 5b), which indicated that the balance
of proBDNF and BDNF pathways were dysregulated in
patients with chronic ethanol consumption.
Discussion
Many studies suggest that the reduction of hippocampal
volume and cognitive impairment are associated with
chronic alcohol consumption in alcohol dependence
patients19,21–24. The abnormality in BDNF signalling
pathway in alcohol dependence may cause the cognitive
impairment and brain atrophy. Our ELISA, quantitative
real-time PCR and western blotting results proved each
other and also supported the hypothesis. We found the
results that in alcohol dependence patients, the mRNA
levels of BDNF and TrkB were downregulated which
leading to the proteins they translated into changed in
line. All the results indicated that the expression of
proBDNF/p75NTR pathway was evidently enhanced while
mBDNF/TrkB pathway was suppressed in alcohol
dependence patients, suggesting that neurotrophic and
neurodegenerative balance was broken. ProBDNF binds to
p75NTR and sortilin, which plays subsequent biological
effects, such as the inhibition of neuronal regeneration and
increase in neuronal apoptosis10,25, reduction in neuronal
migration11 and increase in neurite growth collapses12.
Although in our present experiment, the mRNA and
protein levels of sortilin were not elevated significantly in
alcohol dependence group due to our small sample size, it
does not mean that sortilin is not important in the neu-
rodegeneration roles with proBDNF and p75NTR. The
reduced expressions of mBDNF and TrkB would cause
reduction of neurogenesis and neuroregeneration. The
outcomes of all these neurotrophic dysregulations were
likely underlying the cognitive dysfunctions and even
brain atrophy in patients with alcohol dependence. As
proBDNF and its receptors inhibit the proliferation and
migration of neuronal progenitors11, the reduction in
neurogenesis in alcohol dependence26,27 may be likely due
to the upregulation of proBDNF and its receptors.
BDNF is not only presented in the nervous system but
also in the peripheral blood in humans and rats where the
level is higher than that in the brain. Previous studies have
shown that BDNF can cross the blood–brain barrier, so
the serum level may reflect the level of BDNF in the
brain28,29, and the BDNF level is relatively stable in the
human and other adult primates30. However, the results
of BDNF expression in serum in the alcohol dependence
were not consistent. Some reported no significant changes
of BDNF serum level in alcohol dependence patients as
compared with healthy controls31,32. In contrast, Huang31
found a significant increase in serum BDNF. Lee33 found
that plasma BDNF and NGF levels were higher in patients
with alcohol dependence than in the healthy subjects.
These conflicting results may be owing to the non-specific
detection of both proBDNF and mBDNF with commercial
ELISA kits34. As proBDNF and mBDNF have different,
even opposite functions, it is essential to distinguish
mBDNF from proBDNF by ELISA or by western blots.
We used our own ELISA kit in this research, which spe-
cifically recognised mBDNF rather than the other neu-
rotrophic factors18,20,34. With this ELISA kit, we found
that the serum mBDNF levels of alcohol dependence
patients were lower than the control group. These results
suggested that under chronic ethanol exposure, the
proBDNF/mBDNF balance was broken down. The
enhanced activation of proBDNF/p75NTR signalling
pathway may cause neurodegeneration and result in
symptoms such as cognitive dysfunction, memory loss
and brain atrophy due to the chronic ethanol intoxication.
Because mBDNF is a cleaved product from proBDNF, it is
reasonable that proBDNF and mBDNF were negatively
correlated in both control and alcohol dependence
groups. However, the ratio of proBDNF to mBDNF in the
alcohol dependence group was much higher than in the
control group. This result suggested that the conversion



































Fig. 3 The serum levels of mBDNF and TrkB in patients with
alcohol dependence and healthy controls. The serum level of
mBDNF (a) and TrkB (b) were decreased in alcohol dependence group
(n = 30) compared to the controls (n = 50). The data of mBDNF were
presented in median + IQR and analysed by Mann–Whitney U-test.
The data of TrkB were presented in mean ± SEM and analysed by
Student’s t-test (*P < 0.05, **P < 0.01)
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from proBDNF to mature BDNF in the alcohol-dependent
subjects was abnormally regulated. Given mBDNF was
generated from proBDNF by the cleavage enzyme such as
MMP-7 and tPA35,36, future studies should elucidate
whether proBDNF cleaving enzymes are altered in alcohol
dependence.
ProBDNF, mBDNF and their own receptors in the
blood of alcoholic subjects can be biomarkers reflecting
the amount of ethanol consumption. The ethanol intake
was significantly increased in both the CREB hetero-
zygous mice37 and BDNF heterozygous rats38 in which the
BDNF expression was decreased. The degree of brain
atrophy was also proportional to alcohol consumption39,
which also related to the cognitive functions. In the pre-
sent study, we found that the levels of proBDNF, p75NTR
and sortilin in the blood were positively correlated with
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Fig. 4 The correlations of average daily alcohol consumption and lymphocyte protein levels of proBDNF, p75NTR, sortilin or TrkB in
patients with alcohol dependence. The average daily alcohol consumption was positively correlated with the lymphocyte protein levels of
proBDNF (a, n = 27), p75NTR (b, n = 27) and sortilin (c, n = 27); but negatively correlated with the lymphocyte protein levels of TrkB (d, n = 27), serum
levels of TrkB (f, n = 30) and mBDNF (e, n = 30) in patients with alcohol dependence. All the data were analysed by Spearman’s correlation test
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the average daily alcohol consumption, while the levels of
mBDNF and TrkB in the serum were negatively correlated
with the daily average alcohol consumption. We specu-
lated that if neurons were severely damaged, and the
regeneration was highly inhibited, the mBDNF level
would decline, rather than increase. Therefore, proBDNF
was directly proportional to the amount of alcohol, indi-
cating that the more alcohol intake, the less the mBDNF
was cleaved from proBDNF, and the more severe damage
done to the neurons. Therefore, the chronic drinking of
patients would have significantly reduced cortical and
white matter, because of the increased level of proBDNF,
and the reduction of mBDNF. These results suggested
that the BDNF related signalling molecules were sensitive
biomarkers in response to the alcohol consumption.
Specifically, ethanol can enhance the neurodegenerative
signals including proBDNF, p75NTR and sortilin, but
decrease the neurotrophic signals such as mBDNF and
TrkB. Jeanblanc40,41 reported that the alcohol intake was
increased by K252a (Trk receptor inhibitor) treatment in
rats, suggesting that BDNF-mediated signalling cascade
might control alcohol intake. This was consistent with our
results that the reduction of mBDNF signalling pathway
may affect alcohol intake. And it also prompted that the
alcohol consumption would impact on the expressions of
proBDNF and mBDNF, as well as their cascade receptors.
In summary, the balance between proBDNF/p75NTR/
sortilin and mBDNF/TrkB signalling pathways in alcohol
dependence was dysregulated. Our findings suggested
that the levels of proBDNF, mBDNF and their receptors
(p75NTR, sortilin and TrkB) in the blood can be a clue for
alcohol dependence research and also therapeutic meth-
ods for the future.
Although the present findings are interesting, there are
still several limitations in this study: such as single sex
(males only), small sample size in each experimental
group and patients with only high AUDIT scores. In
addition, because our study is based on clinical samples,
all the patients recruited receive the oral Oxazepam
immediately after hospitalisation. As the blood samples
were collected in the next morning 6.00–7.00 a.m. after
hospitalization, the effect of the drug and the effect of the
alcohol withdrawal (no more than 24 h) on the parameters
measured cannot be completely excluded. These limita-
tions may generate considerable errors in data inter-
pretation and conclusion.
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Fig. 5 The ratio of proBDNF to mBDNF protein level in the blood of patients with alcohol dependence and of the controls. a Scattered plot
of the protein level of proBDNF in lymphocytes to the protein level of mBDNF in serum in the control group and alcohol dependence group with
Spearman’s correlation test. b The relative ratio of the protein level of proBDNF in lymphocytes to the protein level of mBDNF in serum was
significantly higher in patients with alcohol dependence (n = 27) compared to healthy controls (n = 45) (Fig. 5b). The data were analysed by Student’s
t-test (***P < 0.001)
Zhou et al. Translational Psychiatry  (2017) 7:2 Page 9 of 10
Translational Psychiatry
Received: 22 May 2017 Revised: 8 August 2017 Accepted: 20 August 2017
References
1. Cui, C. et al. Brain pathways to recovery from alcohol dependence. Alcohol 49,
435–452 (2015).
2. Kyzar, E. J. & Pandey, S. C. Molecular mechanisms of synaptic remodeling in
alcoholism. Neurosci. Lett. 601, 11–19 (2015).
3. Moonat, S., Starkman, B. G., Sakharkar, A. & Pandey, S. C. Neuroscience of
alcoholism: Molecular and cellular mechanisms. Cell. Mol. Life Sci. 67, 73–88
(2010).
4. Gabbard GO. Alcohol-related disorders. Treatments of Psychiatric Disorders.
Fourth edn. American Psychiatric Press Inc.: Washington DC, USA, 2007,
pp 199.
5. Heberlein, A. et al. Do changes in the BDNF promoter methylation
indicate the risk of alcohol relapse? Eur. Neuropsychopharmacol. 25, 1892–1897
(2015).
6. Heaton, M. B., Kim, D. S. & Paiva, M. Neurotrophic factor protection against
ethanol toxicity in rat cerebellar granule cell cultures requires phosphatidyli-
nositol 3-kinase activation. Neurosci. Lett. 291, 121–125 (2000).
7. Heaton, M. B., Paiva, M. & Siler-Marsiglio, K. Ethanol Influences on bax trans-
location, mitochondrial membrane potential, and reactive oxygen species
generation are modulated by vitamin E and brain-derived neurotrophic factor.
Alcohol Clin. Exp. Res. 35, 1122–1133 (2011).
8. Sakai, R. et al. Attenuation of brain derived neurotrophic factor (BDNF) by
ethanol and cytoprotective effect of exogenous BDNF against ethanol
damage in neuronal cells. J. Neural. Transm. 112, 1005–1013 (2005).
9. Yang, J. et al. proBDNF negatively regulates neuronal remodeling, synaptic
transmission, and synaptic plasticity in hippocampus. Cell Rep. 7, 796–806
(2014).
10. Teng, H. K. et al. ProBDNF induces neuronal apoptosis via activation of a
receptor complex of p75NTR and sortilin. J. Neurosci. 25, 5455–5463 (2005).
11. Xu, Z. Q. et al. Endogenous proBDNF is a negative regulator of migration of
cerebellar granule cells in neonatal mice. Eur. J. Neurosci. 33, 1376–1384 (2011).
12. Sun, Y. et al. ProBDNF collapses neurite outgrowth of primary neurons by
activating RhoA. PLoS ONE 7, e35883 (2012).
13. Stragier, E. et al. Ethanol-induced epigenetic regulations at the bdnf gene in
C57BL/6J mice. Mol. Psychiatr. 20, 405–412 (2015).
14. Bazovkina, D. V., Tsybko, A. S., Filimonova, E. A., Ilchibaeva, T. V. & Naumenko, V.
S. Influence of chronic alcohol treatment on the expression of the Bdnf, Bax,
Bcl-xL, and CASP3 genes in the mouse brain: Role of the C1473G poly-
morphism in the gene encoding tryptophan hydroxylase 2. Mol. Biol. (Mosk).
50, 302–310 (2016).
15. Yang, J. W. et al. Region-specific expression of precursor and mature brain-
derived neurotrophic factors after chronic alcohol exposure. Am. J. Drug
Alcohol Abuse 29, 1–7 (2016).
16. Xu, R., Duan, S. R., Zhao, J. W. & Wang, C. Y. Changes in expression of BDNF
and its receptors TrkB and p75NTR in the hippocampus of a dog model of
chronic alcoholism and abstinence. Braz. J. Med. Biol. Res. 48, 703–710
(2015).
17. Darcq, E. et al. The neurotrophic factor receptor p75 in the rat Dorsolateral
striatum drives excessive alcohol drinking. J. Neurosci. 36, 10116–10127 (2016).
18. Zhou, L. et al. Upregulation of blood proBDNF and its receptors in major
depression. J. Affect. Disord. 150, 776–778 (2013).
19. Fauchais, A. L. et al. Role of endogenous brain-derived neurotrophic factor and
sortilin in b cell survival. J. Immunol. 181, 3027–3038 (2008).
20. Lim, Y., Zhong, J. H. & Zhou, X. F. Development of mature BDNF-specific
sandwich ELISA. J. Neurochem. 134, 75–85 (2015).
21. Morris, S. A., Eaves, D. W., Smith, A. R. & Nixon, K. Alcohol inhibition of neu-
rogenesis: a mechanism of hippocampal neurodegeneration in an adolescent
alcohol abuse model. Hippocampus 20, 596–607 (2010).
22. Hanson, K. L., Cummins, K., Tapert, S. F. & Brown, S. A. Changes in neu-
ropsychological functioning over 10 years following adolescent substance
abuse treatment. Psychol. Addict. Behav. 25, 1 (2011).
23. Ozsoy, S., Durak, A. C. & Esel, E. Hippocampal volumes and cognitive
functions in adult alcoholic patients with adolescent-onset. Alcohol 47, 9–14
(2013).
24. Trantham-Davidson, H. et al. Alcohol disrupts dopamine receptor activity and
the cognitive function of the medial prefrontal cortex. J. Neurosci. 34,
3706–3718 (2014).
25. Skeldal, S. et al. Mapping of the interaction site between sortilin and the p75
neurotrophin receptor reveals a regulatory role for the sortilin intracellular
domain in p75 neurotrophin receptor shedding and apoptosis. J. Biol. Chem.
287, 43798–43809 (2012).
26. Anderson, M. L., Nokia, M. S., Govindaraju, K. P. & Shors, T. J. Moderate drinking?
Alcohol consumption significantly decreases neurogenesis in the adult hip-
pocampus. Neuroscience 224, 202–209 (2012).
27. Briones, T. L. & Woods, J. Chronic binge-like alcohol consumption in adoles-
cence causes depression-like symptoms possibly mediated by the effects of
BDNF on neurogenesis. Neuroscience 254, 324–334 (2013).
28. Radka, S. F., Hoist, P. A., Fritsche, M. & Altar, C. A. Presence of brain-derived
neurotrophic factor in brain and human and rat but not mouse serum
detected by a sensitive and specific immunoassay. Brain Res. 709, 122–130
(1996).
29. Karege, F. et al. Decreased serum brain-derived neurotrophic factor levels in
major depressed patients. Psychiatr. Res. 109, 143–148 (2002).
30. Mori, T., Shimizu, K. & Hayashi, M. Levels of serum brain-derived neurotrophic
factor in primates. Primates 44, 167–169 (2003).
31. Huang, M. C. et al. Alterations of serum brain-derived neurotrophic factor
levels in early alcohol withdrawal. Alcohol 43, 241–245 (2008).
32. Heberlein, A. et al. BDNF and GDNF serum levels in alcohol-dependent
patients during withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatr. 34,
1060–1064 (2010).
33. Lee, B. C. et al. Relation between plasma brain-derived neurotrophic factor and
nerve growth factor in the male patients with alcohol dependence. Alcohol
43, 265–269 (2009).
34. Johnson, M. E., Lim, Y., Senthilkumaran, M., Zhou, X. F. & Bobrovskaya, L.
Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model
of Parkinson’s disease. J. Chem. Neuroanat. 70, 33–41 (2015).
35. Pang, P. T. et al. Cleavage of proBDNF by tPA/Plasmin is essential for long-term
hippocampal plasticity. Science 306, 487–491 (2004).
36. Le, A. P. & Friedman, W. J. Matrix metalloproteinase-7 regulates cleavage of
pro-nerve growth factor and is neuroprotective following Kainic Acid-induced
seizures. J. Neurosci. 32, 703–712 (2012).
37. Pandey, S. C., Roy, A., Zhang, H. & Xu, T. Partial deletion of the cAMP response
element-binding protein gene promotes alcohol-drinking behaviors. J. Neu-
rosci. 24, 5022–5030 (2004).
38. Pandey, S. C., Zhang, H., Roy, A. & Misra, K. Central and medial amygdaloid
brain-derived neurotrophic factor signalling plays a critical role in alcohol-
drinking and anxiety-like behaviors. J. Neurosci. 26, 8320–8331 (2006).
39. Paul, C. A. et al. Association of alcohol consumption with brain volume in the
Framingham study. Arch. Neurol. 65, 1363–1367 (2008).
40. Jeanblanc, J. et al. The dopamine D3 receptor is part of a homeostatic
pathway regulating ethanol consumption. J. Neurosci. 26, 1457–1464 (2006).
41. Jeanblanc, J., Coune, F., Botia, B. & Naassila, M. Brain-derived neurotrophic
factor mediates the suppression of alcohol self-administration by memantine.
Addict. Biol. 19, 758–769 (2014).
Zhou et al. Translational Psychiatry  (2017) 7:2 Page 10 of 10
Translational Psychiatry
